April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Nerve Growth Factor Promotes Endothelial Progenitor Cell-Mediated Angiogenic Responses
Author Affiliations & Notes
  • C. S. Jadhao
    Pharmacology and Therapeutics,
    University of Florida, Gainesville, Florida
  • A. D. Bhatwadekar
    Pharmacology and Therapeutics,
    University of Florida, Gainesville, Florida
  • M. E. Boulton
    Anatomy and Cell Biology,
    University of Florida, Gainesville, Florida
  • J. J. Steinle
    Ophthalmology, Univ of Tennessee Hlth Sci Ctr, Memphis, Tennessee
  • M. B. Grant
    Pharmacology and Therapeutics,
    University of Florida, Gainesville, Florida
  • Footnotes
    Commercial Relationships  C.S. Jadhao, None; A.D. Bhatwadekar, None; M.E. Boulton, None; J.J. Steinle, None; M.B. Grant, None.
  • Footnotes
    Support  NIH grants 2RO1 EY012601-08 , 2RO1 EY007739-17, R01 EY018358
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2668. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. S. Jadhao, A. D. Bhatwadekar, M. E. Boulton, J. J. Steinle, M. B. Grant; Nerve Growth Factor Promotes Endothelial Progenitor Cell-Mediated Angiogenic Responses. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2668.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Retinal neuronal cells are dysfunctional in diabetes and in response to injury express nerve growth factor (NGF) which, in some settings, can be pro-angiogenic. We postulated that the NGF that accompanies retinal injury/ischemia will a) contribute to an "angiogenic switch" in CD34+ cells taking them from beneficial reparative cells to cells that participate in pathological angiogenesis and b) have little effect on the resident endothelial cells of the retinal vasculature.

Methods: : CD34+ cells were isolated from healthy volunteers (n=10) using immunomagnetic separation. Human retinal endothelial cells (HREC) were obtained from retinas of healthy human donors (n=3). Cell proliferation in response to NGF (1, 2 and 4pM) was determined by cell counts for CD34+ cells and MTT assay for HREC. Migration of CD34+ cells and HREC was studied using a modified Boyden chamber assay. NGF stimulated CD34+ cell incorporation into HREC tubule formation was evaluated using 3-dimensional (3D) extracellular matrix. NGF receptor activation was assessed by Western blot analysis.

Results: : NGF induced a dose-dependent increase (1.5-3-fold; p<0.001) in proliferation of CD34+ cells at 24 hrs compared to controls but had no effect on HREC proliferation. However, NGF stimulated HREC migration in a dose-dependent manner. Pretreatment of CD34+ cells with NGF increased migration to SDF-1 (p<0.05). NGF-treated CD34+ cells enhanced in vitro tube formation by HRECs 2-fold (p<0.05) as assessed by increases in numbers of sprouts in a 3D model of angiogenesis Western blotting of cell lysates with phospho-specific antibodies revealed phosphorylation of TrKA (receptor for NGF) in CD34+ and HRECs. NGF stimulation resulted in activation of Akt in HRECs and ERK1 in CD34+ cells while pretreatment with LY294002 (PI3K inhibitor) and PD98059 (MAPK inhibitor) blocked this phosphorylation response by 1.2-fold and 5-fold respectively.

Conclusions: : NGF differentially regulates the angiogenic potential of CD34+ cells and resident endothelial cells and may contribute to the angiogenic switch in CD34+ cells which is associated with the pathological neovascularization in diabetic retinopathy.

Keywords: diabetic retinopathy • growth factors/growth factor receptors • neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.